Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals

mBio

Volumn 6, Issue 2, 2015, Pages

  Bassis, Christine M ^a   Erb Downward, John R ^a   Dickson, Robert P ^a   Freeman, Christine M ^a,b   Schmidt, Thomas M ^a   Young, Vincent B ^a   Beck, James M ^c,d   Curtis, Jeffrey L ^a,b   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c Veterans Affairs Eastern Colorado Healthcare System   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; BACTERIAL DNA; RIBOSOME DNA;

AMPLICON; ARTICLE; BACTERIUM CONTAMINATION; CONTROLLED STUDY; CORYNEBACTERIUM; FEMALE; FUSOBACTERIUM; GASTRIC SUCTION; HUMAN; LUNG LAVAGE; LUNG MICROFLORA; MALE; MICROBIAL COMMUNITY; MICROFLORA; MOUTH CAVITY; MOUTH FLORA; NEISSERIA; NONHUMAN; NOSE CAVITY; NOSE SMEAR; PASTEURELLACEAE; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM; PYROSEQUENCING; SPECIES RICHNESS; STAPHYLOCOCCUS; STOMACH MICROFLORA; STREPTOCOCCUS; BACTERIUM; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; LUNG; MICROBIOLOGY; MOLECULAR GENETICS; MOUTH; NORMAL HUMAN; REAL TIME POLYMERASE CHAIN REACTION; STOMACH;

BACTERIA (MICROORGANISMS); PREVOTELLA;

BACTERIA; DNA, BACTERIAL; DNA, RIBOSOMAL; HEALTHY VOLUNTEERS; HUMANS; LUNG; MICROBIOTA; MOLECULAR SEQUENCE DATA; MOUTH; NASAL CAVITY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; STOMACH;

EID: 84929493450     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00037-15     Document Type: Article

References (44)

1. Dickson RP, Erb-Downward JR, Huffnagle GB. 2013. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7:245–257. http://dx.doi.org/10.1586/ers.13.24.
2. Dickson RP, Erb-Downward JR, Huffnagle GB. 2014. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir. Med. 2:238-246. http://dx.doi.org/10.1016/S2213-2600(14)70028-1.
3. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO. 2010. Disordered microbial communities in asthmatic airways. PLoS One 5:e8578. http://dx.doi.org/10.1371/journal.pone.0008578.
4. Huang YJ, Lynch SV. 2011. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med 5:-809–821. http://dx.doi.org/10.1586/ers.11.76.
5. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. http://dx.doi.org/10.1038/nature11234.
6. Gleeson K, Eggli DF, Maxwell SL. 1997. Quantitative aspiration during sleep in normal subjects. Chest 111:1266-1272. http://dx.doi.org/10.1378/chest.111.5.1266.
7. Huxley EJ, Viroslav J, Gray WR, Pierce AK. 1978. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 64:564–568. http://dx.doi.org/10.1016/0002-9343(78)90574-0.
8. Quinn LH, Meyer OO. 1929. The relationship of sinusitis and bronchiectasis. Arch. Otolaryngol Head Neck Surg 10:152–165. http://dx.doi.org/10.1001/archotol.1929.00620050048003.
9. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. 2011. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184:957–963. http://dx.doi.org/10.1164/rccm.201104-0655OC.
10. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB. 2011. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6:e16384. http://dx.doi.org/10.1371/journal.pone.0016384.
11. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV. 2011. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127:372–381.e1-3. http://dx.doi.org/10.1016/j.jaci.2010.10.048.
12. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. 2012. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7: e4 7 3 0 5. http://dx.doi.org/10.1371/journal.pone.0047305.
13. Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ, Weiden MD. 2013. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1:19. http://dx.doi.org/10.1186/2049-2618-1-19.
14. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. 2012. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185:1073–1080. http://dx.doi.org/10.1164/rccm.201111-2075OC.
15. Dickson RP, Martinez FJ, Huffnagle GB. 2014. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384:691–702. http://dx.doi.org/10.1016/S0140-6736(14)61136-3.
16. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. 2014. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One 9:e97214. http://dx.doi.org/10.1371/journal.pone.0097214.
17. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM. 2013. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187:1067–1075. http://dx.doi.org/10.1164/rccm.201210-1913OC.
18. Yang I, Nell S, Suerbaum S. 2013. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 37:736-761. http://dx.doi.org/10.1111/1574-6976.12027.
19. Delgado S, Cabrera-Rubio R, Mira A, Suárez A, Mayo B. 2013. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol 65:763–772. http://dx.doi.org/10.1007/s00248-013-0192-5.
20. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. 2006. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732–737. http://dx.doi.org/10.1073/pnas.0506655103.
21. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA, NISC Comparative Sequencing Program. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324: 1190–1192. http://dx.doi.org/10.1126/science.1171700.
22. Charlson ES, Chen J, Custers-Allen R, Bittinger K, Li H, Sinha R, Hwang J, Bushman FD, Collman RG. 2010. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One 5:e15216. http://dx.doi.org/10.1371/journal.pone.0015216.
23. Rasmussen TT, Kirkeby LP, Poulsen K, Reinholdt J, Kilian M. 2000. Resident aerobic microbiota of the adult human nasal cavity. APMIS 108: 663–675. http://dx.doi.org/10.1034/j.1600-0463.2000.d01-13.x.
24. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WOC, Moffatt MF, Johnston SL. 2013. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188: 1224–1231. http://dx.doi.org/10.1164/rccm.201302-0341OC.
25. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV. 2010. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. Omics 14:9–59. http://dx.doi.org/10.1089/omi.2009.0100.
26. Sadighi Akha AA, Theriot CM, Erb-Downward JR, McDermott AJ, Falkowski NR, Tyra HM, Rutkowski DT, Young VB, Huffnagle GB. 2013. Acute infection of mice with Clostridium difficile leads to eIF2alpha phosphorylation and pro-survival signalling as part of the mucosal inflammatory response. Immunology 140:111–122. http://dx.doi.org/10.1111/imm.12122.
27. Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. 2014. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol 52:3605–3613. http://dx.doi.org/10.1128/JCM.01028-14.
28. Bertolini V, Gandolfi I, Ambrosini R, Bestetti G, Innocente E, Rampazzo G, Franzetti A. 2013. Temporal variability and effect of environmental variables on airborne bacterial communities in an urban area of northern Italy. Appl Microbiol Biotechnol 97:6561-6570. http://dx.doi.org/10.1007/s00253-012-4450-0.
29. Bowers RM, McLetchie S, Knight R, Fierer N. 2011. Spatial variability in airborne bacterial communities across land-use types and their relationship to the bacterial communities of potential source environments. ISME J 5:601–612. http://dx.doi.org/10.1038/ismej.2010.167.
30. Bowers RM, Sullivan AP, Costello EK, Collett JL, Jr., Knight R, Fierer N. 2011. Sources of bacteria in outdoor air across cities in the midwestern United States. Appl Environ Microbiol 77:6350–6356. http://dx.doi.org/10.1128/AEM.05498-11.
31. Fierer N, Liu Z, Rodríguez-Hernández M, Knight R, Henn M, Hernandez MT. 2008. Short-term temporal variability in airborne bacterial and fungal populations. Appl Environ Microbiol 74:200-207. http://dx.doi.org/10.1128/AEM.01467-07.
32. Munyard P, Bush A. 1996. How much coughing is normal? Arch Dis Child 74:531–534. http://dx.doi.org/10.1136/adc.74.6.531.
33. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX. 2003. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 111:1589–1602. http://dx.doi.org/10.1172/JCI16889.
34. Larsen JM, Musavian HS, Butt TM, Ingvorsen C, Thysen AH, Brix S. 2015. COPD and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote TLR2-independent lung inflammation and pathology. Immunology 144:333–342. http://dx.doi.org/10.1111/imm.12376.
35. Larsen JM, Steen-Jensen DB, Laursen JM, Søndergaard JN, Musavian HS, Butt TM, Brix S. 2012. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 7:e31976. http://dx.doi.org/10.1371/journal.pone.0031976.
36. Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, Bushman FD, Artis D. 2010. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3:148–158. http://dx.doi.org/10.1038/mi.2009.132.
37. Bassis CM, Tang AL, Young VB, Pynnonen MA. 2014. The nasal cavity microbiota of healthy adults. Microbiome 2:27. http://dx.doi.org/10.1186/2049-2618-2-27.
38. Bassis CM, Theriot CM, Young VB. 2014. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother 58: 2767–2774. http://dx.doi.org/10.1128/AAC.02262-13.
39. Schloss PD, Gevers D, Westcott SL. 2011. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6:e27310. http://dx.doi.org/10.1371/journal.pone.0027310.
40. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537–7541. http://dx.doi.org/10.1128/AEM.01541-09.
41. Hashway SA, Bergin IL, Bassis CM, Uchihashi M, Schmidt KC, Young VB, Aronoff DM, Patton DL, Bell JD. 2014. Impact of a hormonereleasing intrauterine system on the vaginal microbiome: a prospective baboon model. J Med Primatol 43:89-99. http://dx.doi.org/10.1111/jmp.12090.
42. Sloan WT, Lunn M, Woodcock S, Head IM, Nee S, Curtis TP. 2006. Quantifying the roles of immigration and chance in shaping prokaryote community structure. Environ Microbiol 8:732–740. http://dx.doi.org/10.1111/j.1462-2920.2005.00956.x.
43. Anderson MJ. 2001. A new method for non-parametric multivariate analysis of variance. Austral Ecol 26:32-46. http://www.entsoc.org/PDF/MUVE/6_NewMethod_MANOVA1_2.pdf.
44. Yue JC, Clayton MK. 2005. A similarity measure based on species proportions. Commun Stat Theory Methods 34:2123–2131. http://dx.doi.org/10.1080/STA-200066418